It's hard to tell when 30c will go but it seems like it has to sooner or later now with all the recent news. The results were certainly phenomenal. This will also be a much busier half year in terms of news flow, we already have a few news events locked in such as October financial results, the AGM, November reimbursement news, as well as other likely catalysts such as approvals in other markets (seems quite overdue now) and for other indications, as well as data from clinical trials. Who knows, maybe a bit of 2RT news to end the year with a bang
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-124
-
- There are more pages in this discussion • 384 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $36.64M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $27.50K | 171.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29975 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 85398 | 4 |
View Market Depth
| Last trade - 11.24am 04/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |